Literature DB >> 6150769

Development of a gonorrhoea vaccine: prospects, strategies and tactics.

E C Gotschlich.   

Abstract

Entities:  

Keywords:  Antibodies; Antibody Formation; Biology; Delivery Of Health Care; Diseases--prevention and control; Examinations And Diagnoses; Health; Health Services; Immunity; Immunity, Natural; Immunization; Immunologic Factors; Infections; Laboratory Examinations And Diagnoses; Measurement; Medicine; Physiology; Prevalence; Preventive Medicine; Primary Health Care; Public Health; Reproductive Tract Infections; Sexually Transmitted Diseases--analysis; Sexually Transmitted Diseases--prevention and control; Vaccination

Mesh：

Substances：

Year:  1984        PMID： 6150769      PMCID： PMC2536225     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  5 in total

1.  Studies on gonococcus infection. XII. Colony color and opacity varienats of gonococci.

Authors:  J Swanson
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

2.  Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing.

Authors:  B W Catlin
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

3.  The human fallopian tube: a laboratory model for gonococcal infection.

Authors:  M E Ward; P J Watt; J N Robertson
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

4.  Species specificity of attachment and damage to oviduct mucosa by Neisseria gonorrhoeae.

Authors:  A P Johnson; D Taylor-Robinson; Z A McGee
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

5.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490
  5 in total
  6 in total

1.  Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes.

Authors:  W Jiskoot; T Teerlink; M M Van Hoof; K Bartels; V Kanhai; D J Crommelin; E C Beuvery
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

2.  Induction of mucosal immunoglobulin A immune response by preparations of Neisseria gonorrhoeae porin proteins.

Authors:  S H Jeurissen; T Sminia; E C Beuvery
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

3.  Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection.

Authors:  F A Plummer; J N Simonsen; H Chubb; L Slaney; J Kimata; M Bosire; J O Ndinya-Achola; E N Ngugi
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

4.  Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.

Authors:  F A Plummer; H Chubb; J N Simonsen; M Bosire; L Slaney; I Maclean; J O Ndinya-Achola; P Waiyaki; R C Brunham
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

5.  Bacterial entry and intracellular processing of Neisseria gonorrhoeae in epithelial cells: immunomorphological evidence for alterations in the major outer membrane protein P.IB.

Authors:  J F Weel; C T Hopman; J P van Putten
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

Review 6.  Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines.

Authors:  Helen Petousis-Harris; Fiona J Radcliff
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.